NGM Biopharmaceuticals Inc buy Citigroup Inc.
Start price
03.05.23
/
50%
€3.48
Target price
03.05.24
€5.43
Performance (%)
-59.48%
End price
04.05.24
-
Summary
This prediction is currently being closed. Massive losses of -59.48% have been the result for the BUY prediction by Citigroup_Inc_. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| NGM Biopharmaceuticals Inc | - | - | - |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Citigroup_Inc_ for this prediction
In the thread NGM Biopharmaceuticals Inc diskutieren
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for NGM provided by MarketBeat
In the thread Trading NGM Biopharmaceuticals Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten